|1|Non-functioning pancreatic endocrine tumors: eleven-year experience in a single institute. (24965405)
Fragulidis G.P.... Polydorou A.
|2|Cytologic features of lipid-rich variant of pancreatic endocrine tumor-Report of two cases with literature review. (23749767)
Zhang Z.... Gu M.
|3|IMP3, NESP55, TTF-1 and CDX2 serve as an immunohistochemical panel in the distinction among small-cell carcinoma, gastrointestinal carcinoid, and pancreatic endocrine tumor metastasized to the liver. (22495359)
Denby K.S.... Xu H.
|4|Current surgical management of pancreatic endocrine tumor liver metastases. (21669565)
Pavlidis T.E.... Sakantamis A.K.
|5|Curative resection of a huge malignant pancreatic endocrine tumor by pancreatoduodenectomy with portal and superior mesenteric vein resection and reconstruction using the right ovarian vein: report of a case. (21874427)
Ochiai T.... Yamazaki S.
|6|Pax8 detection in well-differentiated pancreatic endocrine tumors: how reliable is it? (22067332)
Moreno C.M.... Gauthier B.R.
|7|Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection. (21690450)
Norton J.A.... Jensen R.T.
|8|Profiling of somatostatin receptor subtype expression by quantitative PCR and correlation with clinicopathological features in pancreatic endocrine tumors. (20717067)
Nakayama Y.... Yagihashi S.
|9|KIT is an independent prognostic marker for pancreatic endocrine tumors: a finding derived from analysis of islet cell differentiation markers. (19574886)
Zhang L.... Lloyd R.V.
|10|Pancreatic endocrine tumor in multiple endocrine neoplasia type 1 syndrome with intraductal growth into the main pancreatic duct. (19307930)
Fassan M.... Parenti A.R.
|11|Immunohistochemical and clinicopathological correlation of the metastasis-associated gene 1 (MTA1) expression in benign and malignant pancreatic endocrine tumors. (19377441)
Hofer M.D.... NosAc V.
|12|Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors. (18997736)
Couvelard A.... Ruszniewski P.
|13|Proliferative rate in endoscopic ultrasound fine-needle aspiration of pancreatic endocrine tumors: correlation with clinical behavior. (19347828)
Alexiev B.A.... Ioffe O.B.
|14|VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors. (19690016)
Schmitt A.M.... Perren A.
|15|Treatment of a pancreatic endocrine tumor by ethanol injection guided by endoscopic ultrasound. (19090457)
Muscatiello N.... Ierardi E.
|16|Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3, and FIH Is associated with tumor aggressiveness in pancreatic endocrine tumors. (18927305)
Couvelard A.... Bedossa P.
|17|Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. (18798544)
Jensen R.T.... Norton J.A.
|18|Re: Treatment of a pancreatic endocrine tumor by ethanol injection (PEI) guided by endoscopic ultrasound. (19009494)
JA1rgensen C.... StAPlzel U.
|19|Treatment of a pancreatic endocrine tumor by ethanol injection (PEI) guided by endoscopic ultrasound. (18633893)
Muscatiello N.... Ierardi E.
|20|Pancreatic endocrine tumors-c-erb B2 (Her-2/neu), bcl-2, and p-53 immunohistochemical testing and their value in assessing prognosis. (18091321)
Proca D.M.... Frankel W.L.
|21|Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. (19047107)
Ekeblad S.... Eriksson B.
|22|Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases. (18300808)
Schmitt A.M.... Perren A.
|23|Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function. (17710155)
Lindberg D.... Westin G.
|24|Management of nonfunctioning pancreatic endocrine tumors in the context of multiple endocrine neoplasia type 1 syndrome. (17925918)
Botsios D.... Betsis D.
|25|Lymphatic vessel endothelial hyaluronan receptor 1 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors. (18090227)
|26|Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. (17443844)
Cecconi D.... Righetti P.G.
|27|Clinicopathologic and immunohistochemical correlation in sporadic pancreatic endocrine tumors: possible roles of utrophin and cyclin D1 in malignant progression. (17306326)
Chang M.C.... NosAc V.
|28|Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. (16680581)
Kouvaraki M.A.... Perrier N.D.
|29|Pancreatic endocrine tumor with partial acinar cell differentiation. (17004975)
Minakawa K.... Yanagisawa A.
|30|Spindle cell pancreatic endocrine tumor associated with Cushing's syndrome. (16199900)
Chetty R.... Serra S.
|31|Current advances in the diagnosis and treatment of pancreatic endocrine tumors. (15608508)
Viola K.V.... Sosa J.A.
|32|Ectopic bioactive luteinizing hormone secretion by a pancreatic endocrine tumor, manifested as luteinized granulosa-thecal cell tumor of the ovaries. (15687346)
Piaditis G.... Kovacs K.
|33|Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors. (15053236)
Panzuto F.... Delle Fave G.
|34|Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors. (15501970)
Rubbia-Brandt L.... Pepper M.S.
|35|Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors. (12629131)
Wild A.... Bartsch D.K.
|36|CpG island methylation in carcinoid and pancreatic endocrine tumors. (12584572)
Chan A.O.... Rashid A.
|37|Immunohistochemical analysis of cyclooxygenase (COX)-2 expression in pancreatic endocrine tumors: association with tumor progression and proliferation. (11881729)
Ohike N.... Morohoshi T.
|38|Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors. (11727256)
Srivastava A.... Dayal Y.
|39|Pancreatic endocrine tumors: recent advances. (10436815)
|40|Cellular composition and anatomic distribution in nonfunctioning pancreatic endocrine tumors: immunohistochemical study of 30 cases. (10374408)
Zheng X.... Shen K.
|41|Lack of p53 immunoreactivity in pancreatic endocrine tumors. (8743819)
|42|A pancreatic endocrine tumor arising within a serous cystadenoma of the pancreas. (8604814)
Keel S.B.... Compton C.C.
|43|Immunolocalization of neuropeptide Y in human pancreatic endocrine tumors. (7479336)
Waeber G.... Grouzmann E.
|44|Multihormonal pancreatic endocrine tumor in a European lynx (Lynx lynx). (7725607)
Kirchhof N.... Geiss V.
|45|Glucagon-like peptide 1 immunoreactivity in gastroentero-pancreatic endocrine tumors: a light- and electron-microscopic study. (8062345)
Eissele R.... GAPke B.
|46|Islet amyloid polypeptide and calcitonin gene-related peptide immunoreactivity in amyloid and tumor cells of canine pancreatic endocrine tumors. (1972303)
O'Brien T.D.... Johnson K.H.
|47|Factors that determine cell-specific gene expression in pancreatic endocrine tumor cells. (2559019)
Habener J.F.... Hoeffler J.P.
|48|Multihormonal pancreatic endocrine tumor in a dog with duodenal ulcers and hypertrophic gastropathy. (2839924)
Boosinger T.R.... Pletcher J.M.
|49|Skeletal metastasis from gastrinoma. An uncommon manifestation of pancreatic endocrine tumor. (3791791)
Park H.M.... Nelson R.
|50|Pancreatic endocrine tumor presenting with obstructive jaundice. (6318554)
Di Bisceglie A.M.... Posen J.